These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12465398)

  • 21. A case of metastatic extramammary Paget's disease that responded to combination chemotherapy.
    Yamazaki N; Yamamoto A; Wada T; Ishikawa M; Moriya Y; Nakanishi Y
    J Dermatol; 1999 May; 26(5):311-6. PubMed ID: 10380432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imiquimod therapy for extramammary Paget's disease of the vulva: a viable non-surgical alternative.
    Sanderson P; Innamaa A; Palmer J; Tidy J
    J Obstet Gynaecol; 2013 Jul; 33(5):479-83. PubMed ID: 23815201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Docetaxel Combined With Cisplatin for Metastatic Extramammary Paget Disease.
    Cai H; Xu W; Yu B; Li X; Zhu L; Xu Z; Zhou J; Zheng Y; Zou Q; Zeng Y; Wang X; Xu T
    Clin Genitourin Cancer; 2018 Aug; 16(4):e899-e901. PubMed ID: 29685612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful treatment of three cases of primary extramammary Paget's disease of the vulva with Imiquimod--proposal of a therapeutic schedule.
    Sendagorta E; Herranz P; Feito M; Ramírez P; Floristán U; Feltes R; Benito DM; Casado M
    J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):490-2. PubMed ID: 19840203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I dose-finding study of biweekly irinotecan in combination with fixed doses of 5-fluorouracil/leucovorin, gemcitabine and cisplatin (G-FLIP) in patients with advanced pancreatic cancer or other solid tumors.
    Rachamalla R; Malamud S; Grossbard ML; Mathew S; Dietrich M; Kozuch P
    Anticancer Drugs; 2004 Mar; 15(3):211-7. PubMed ID: 15014353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination Cisplatin-Epirubicin-Paclitaxel Therapy for Metastatic Extramammary Paget's Disease.
    Hirai I; Tanese K; Nakamura Y; Ishii M; Kawakami Y; Funakoshi T
    Oncologist; 2019 Jun; 24(6):e394-e396. PubMed ID: 30846514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anal canal adenocarcinoma with neuroendocrine features accompanying secondary extramammary Paget disease, successfully treated with modified FOLFOX6: a case report.
    Yamaura M; Yamada T; Watanabe R; Kawai H; Hirose S; Tajima H; Sato M; Uchida Y; Suganuma D; Yamamoto Y; Moriwaki T; Hyodo I
    BMC Cancer; 2018 Nov; 18(1):1142. PubMed ID: 30458812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial.
    Reni M; Cordio S; Milandri C; Passoni P; Bonetto E; Oliani C; Luppi G; Nicoletti R; Galli L; Bordonaro R; Passardi A; Zerbi A; Balzano G; Aldrighetti L; Staudacher C; Villa E; Di Carlo V
    Lancet Oncol; 2005 Jun; 6(6):369-76. PubMed ID: 15925814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Palliative first-line treatment with weekly high-dose 5-fluorouracil as 24h-infusion and gemcitabine in metastatic pancreatic cancer (UICC IV).
    Roehrig S; Wein A; Albrecht H; Konturek PC; Reulbach U; Männlein G; Wolff K; Ostermeier N; Hohenberger W; Hahn EG; Boxberger F
    Med Sci Monit; 2010 Mar; 16(3):CR124-131. PubMed ID: 20190682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HER-2/neu targeting for recurrent vulvar Paget's disease A case report and literature review.
    Karam A; Berek JS; Stenson A; Rao J; Dorigo O
    Gynecol Oncol; 2008 Dec; 111(3):568-71. PubMed ID: 18252264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity of gemcitabine and continuous infusion fluorouracil in advanced pancreatic cancer.
    Rauch DP; Maurer CA; Aebi S; Pampallona S; Friess H; Ludwig CU; Büchler MW; Borner MM
    Oncology; 2001; 60(1):43-8. PubMed ID: 11150907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase I-II study of gemcitabine and fluorouracil as a continuous infusion in patients with pancreatic cancer.
    Hidalgo M; Castellano D; Paz-Ares L; Gravalos C; Diaz-Puente M; Hitt R; Alonso S; Cortes-Funes H
    J Clin Oncol; 1999 Feb; 17(2):585-92. PubMed ID: 10080603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma: a dose-finding study.
    Reni M; Cereda S; Bonetto E; Viganò MG; Passoni P; Zerbi A; Balzano G; Nicoletti R; Staudacher C; Di Carlo V
    Cancer Invest; 2007; 25(7):594-8. PubMed ID: 17852117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Basal cell carcinoma within vulvar Paget's disease.
    Ishizawa T; Mitsuhashi Y; Sugiki H; Hashimoto H; Kondo S
    Dermatology; 1998; 197(4):388-90. PubMed ID: 9873182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II study of gemcitabine, cisplatin, and infusional fluorouracil in advanced pancreatic cancer.
    El-Rayes BF; Zalupski MM; Shields AF; Vaishampayan U; Heilbrun LK; Jain V; Adsay V; Day J; Philip PA
    J Clin Oncol; 2003 Aug; 21(15):2920-5. PubMed ID: 12885810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second-line treatment with a combination of continuous 5-fluorouracil, doxorubicin, and mitomycin-C (conti-FAM) in gemcitabine-pretreated pancreatic and biliary tract cancer.
    Lee S; Oh SY; Kim BG; Kwon HC; Kim SH; Rho MH; Kim YH; Rho MS; Jeong JS; Kim HJ
    Am J Clin Oncol; 2009 Aug; 32(4):348-52. PubMed ID: 19363436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful treatment of recurrent extramammary Paget's disease of the vulva with topical imiquimod 5% cream.
    Wang LC; Blanchard A; Judge DE; Lorincz AA; Medenica MM; Busbey S
    J Am Acad Dermatol; 2003 Oct; 49(4):769-72. PubMed ID: 14512941
    [No Abstract]   [Full Text] [Related]  

  • 38. [Two-year survivor in response to gemcitabine-based chemotherapy for advanced pancreatic cancer with multiple lung metastases].
    Takeyama O; Usui Y
    Gan To Kagaku Ryoho; 2005 Feb; 32(2):247-9. PubMed ID: 15751643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) regimen as second-line therapy in patients with progressive or recurrent pancreatic cancer after gemcitabine-containing chemotherapy.
    Reni M; Cereda S; Mazza E; Passoni P; Nicoletti R; Balzano G; Zerbi A; Arcidiacono PG; Staudacher C; Di Carlo V
    Am J Clin Oncol; 2008 Apr; 31(2):145-50. PubMed ID: 18391598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Irinotecan combined with gemcitabine, 5-fluorouracil, leucovorin, and cisplatin (G-FLIP) is an effective and noncrossresistant treatment for chemotherapy refractory metastatic pancreatic cancer.
    Kozuch P; Grossbard ML; Barzdins A; Araneo M; Robin A; Frager D; Homel P; Marino J; DeGregorio P; Bruckner HW
    Oncologist; 2001; 6(6):488-95. PubMed ID: 11743211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.